Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

NEUROPHARMACOLOGY

卷:61

Review

Halberstadt, Adam L.¹  Geyer, Mark A.¹ 

[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA

关键词: Hallucinogen;    LSD;    Psilocybin;    Serotonin;    Drug discrimination;    Locomotor activity;    Head twitch;    5-HT1A receptor;   

DOI  :  10.1016/j.neuropharm.2011.01.017

来源: Elsevier

【 摘 要 】

Serotonergic hallucinogens produce profound changes in perception, mood, and cognition. These drugs include phenylalkylamines such as mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM), and indoleamines such as (+)-lysergic acid diethylamide (LSD) and psilocybin. Despite their differences in chemical structure, the two classes of hallucinogens produce remarkably similar subjective effects in humans, and induce cross-tolerance. The phenylalkylamine hallucinogens are selective 5-HT2 receptor agonists, whereas the indoleamines are relatively non-selective for serotonin (5-HT) receptors. There is extensive evidence, from both animal and human studies, that the characteristic effects of hallucinogens are mediated by interactions with the 5-HT2A receptor. Nevertheless, there is also evidence that interactions with other receptor sites contribute to the psychopharmacological and behavioral effects of the indoleamine hallucinogens. This article reviews the evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT2 and non-5HT(2) receptors. This article is part of a Special Issue entitled 'Serotonin: The New Wave'. (C) 2011 Elsevier Ltd. All rights reserved.

【 授权许可】

Free